Vaxcyte(PCVX) - 2026 Q1 - Quarterly Report
VaxcyteVaxcyte(US:PCVX)2026-05-07 04:12

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ___________________________________________________ FORM 10-Q ___________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commissi ...

Vaxcyte(PCVX) - 2026 Q1 - Quarterly Report - Reportify